Female Residents Underrepresented in High-Compensation Specialties

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Oct. 2, 2024 -- Female physicians remain underrepresented among residents entering high-compensation specialties, according to a research letter published online Sept. 30 in the Journal of the American Medical Association.

Karina Pereira-Lima, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined national trends in the proportion of female applicants and matriculants to residency programs for high-compensation surgical and nonsurgical pipeline specialties using data from the National Graduate Medical Education Census and Electronic Residency Application Service (2008 to 2022).

The researchers found that of the 490,188 matriculants to pipeline specialties, 25.5 percent entered high-compensation specialties (female, 34.6 percent; surgical, 57.6 percent). There was a significant increase in the proportion of female matriculants to high-compensation specialties from 32.7 percent in 2008 to 40.8 percent in 2022. However, the proportion of matriculants remained lower than the proportion in non-high-compensation specialties (53.0 percent in 2008 to 53.3 percent in 2022). There was a significant decrease in the proportion of female applicants to high-compensation nonsurgical specialties (36.8 percent in 2009 to 34.3 percent in 2022), while the proportion of female applicants to high-compensation surgical specialties increased from 28.1 percent in 2009 to 37.6 percent in 2022.

"Future studies should identify which strategies were successful in attracting women to these specialties and whether they could be implemented by high-compensation nonsurgical specialties," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-03 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords